A detailed history of Larson Financial Group LLC transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Larson Financial Group LLC holds 500 shares of ANIX stock, worth $1,410. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 500 -0.0%
Holding current value
$1,410
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$3.08 - $5.02 $77 - $125
-25 Reduced 4.76%
500 $1,000
Q2 2022

Aug 04, 2022

BUY
$2.55 - $4.1 $63 - $102
25 Added 5.0%
525 $2,000
Q1 2022

May 05, 2022

BUY
$2.5 - $3.42 $1,250 - $1,710
500 New
500 $1,000

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $86.5M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.